Technology Transfer in Brazil

Partnership objective

Expand access to Reyataz® (atazanavir sulfate) for HIV/AIDS patients in Brazil.

BMS will help build the capacity and skills required for the Brazilian government to produce a sustainable, high quality supply of atazanavir. BMS will help build the capacity and skills required for the Brazilian government to produce a sustainable, high quality supply of atazanavir. Copyright BMS

Description of partnership activities and how they address needs and challenges

In November 2011, BMS signed a technology transfer agreement with the Brazilian Ministry of Health to further expand access to Reyataz® (atazanavir sulfate) for patients with HIV/AIDS in Brazil.

BMS will help build the capacity and skills required for the Brazilian government to produce a sustainable, high quality supply of atazanavir and will enable the government to become, over time, the sole source of atazanavir in Brazil.

The agreement transfers the manufacture and distribution of atazanavir sulfate 200 mg and 300 mg capsules in Brazil from BMS to Farmanguinhos, a technical-scientific unit of Fundação Oswaldo Cruz (Fiocruz) and the largest official pharmaceutical laboratory of the Brazilian Ministry of Health, and Nortec Quimica, a local manufacturer of active pharmaceutical ingredients (API).

Summary of impact and forward looking information

BMS has worked collaboratively with the government of Brazil for many years to help improve and sustain access to HIV therapy in the country, in recognition of the government's demonstrated commitment to universal access.

In January 2014, a major milestone in this partnership was reached when the registration of atazanavir sulphate was published under Farmanqquinhos’ name.

Partnership information

Company(ies) Bristol-Myers Squibb

Partner(s) Brazilian Ministry of Health, Fundação Oswaldo Cruz (Fiocruz)

Type of Partner(s) Government, NGOs

Therapeutic Focus Infectious Diseases

Disease(s) HIV/AIDS

Program Type(s) Availability of Treatment - Technology Transfer - Manufacturing and Entrepreneurial Know-How

Targeted Population(s) Men, Mothers, Patients in needs of treatment, People with low income, Women

Region(s) Latin America & Caribbean

Number of Countries 1

Country(ies) Brazil

Start Date 2011

More information BMS Access to Medicines

Anticipated completion date Ongoing